发明授权
US08007792B2 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
有权
针对丙型肝炎病毒E1E2复合物的抗体，HCV颗粒的组合物和药物组合物
- 专利标题： Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
- 专利标题（中）： 针对丙型肝炎病毒E1E2复合物的抗体，HCV颗粒的组合物和药物组合物
-
申请号： US12408080申请日： 2009-03-20
-
公开(公告)号： US08007792B2公开(公告)日： 2011-08-30
- 发明人: Marie-Anne Petit , Colette Jolivet-Reynaud , Christian Trepo
- 申请人： Marie-Anne Petit , Colette Jolivet-Reynaud , Christian Trepo
- 申请人地址： FR Paris FR Marcy-l'Etoile
- 专利权人： INSERM,Biomerieux SA
- 当前专利权人： INSERM,Biomerieux SA
- 当前专利权人地址： FR Paris FR Marcy-l'Etoile
- 代理机构： Young & Thompson
- 优先权： EP03290822 20030401
- 主分类号： A61K39/395
- IPC分类号： A61K39/395
摘要：
New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
公开/授权文献
信息查询
